Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy N Alcalay

Showing results (1-10 of 274) with videos related to

Pageof 28
Sort By:
JAMA Neurology|September 27, 2016
Cytokines as Potential Biomarkers of Parkinson DiseaseRoy N Alcalay
Continuum (Minneapolis, Minn.)|October 12, 2022
Diagnosis and Medical Management of Parkinson DiseaseAvner Thaler, Roy N Alcalay
Advances in Neurobiology|March 30, 2017
Clinical Features of LRRK2 Carriers with Parkinson's DiseaseMeir Kestenbaum, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|May 8, 2020
Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial CompletedSusanne A Schneider, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2025
LRRK2-Associated Parkinson's Disease: Is it a Synucleinopathy After All?Ziv Gan-Or, Roy N Alcalay
Seminars in Neurology|May 17, 2017
Genetic Forms of Parkinson's DiseaseChristine Y Kim, Roy N Alcalay
Parkinsonism & Related Disorders|May 17, 2023
Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson diseaseMichele K York, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|November 11, 2017
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literatureSusanne A Schneider, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|January 31, 2024
Genetics of Parkinson's Disease in Underrepresented Populations: New Studies Pave the WayZiv Gan-Or, Roy N Alcalay
Neurologic Clinics|April 4, 2025
Precision Medicine in Parkinson's DiseaseGadi Maayan Eshed, Roy N Alcalay
Pageof 28

Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
JAMA Neurology|September 27, 2016
Cytokines as Potential Biomarkers of Parkinson DiseaseRoy N Alcalay
Continuum (Minneapolis, Minn.)|October 12, 2022
Diagnosis and Medical Management of Parkinson DiseaseAvner Thaler, Roy N Alcalay
Advances in Neurobiology|March 30, 2017
Clinical Features of LRRK2 Carriers with Parkinson's DiseaseMeir Kestenbaum, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|May 8, 2020
Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial CompletedSusanne A Schneider, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2025
LRRK2-Associated Parkinson's Disease: Is it a Synucleinopathy After All?Ziv Gan-Or, Roy N Alcalay
Seminars in Neurology|May 17, 2017
Genetic Forms of Parkinson's DiseaseChristine Y Kim, Roy N Alcalay
Parkinsonism & Related Disorders|May 17, 2023
Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson diseaseMichele K York, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|November 11, 2017
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literatureSusanne A Schneider, Roy N Alcalay
Movement Disorders : Official Journal of the Movement Disorder Society|January 31, 2024
Genetics of Parkinson's Disease in Underrepresented Populations: New Studies Pave the WayZiv Gan-Or, Roy N Alcalay
Neurologic Clinics|April 4, 2025
Precision Medicine in Parkinson's DiseaseGadi Maayan Eshed, Roy N Alcalay
Pageof 28